Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer

• HASHIMOTO Yasuhiro

  Department of Urology, Hirosaki University Graduate School of Medicine

• IMANISHI Kengo

  Department of Urology, Hirosaki University Graduate School of Medicine

• TOKUI Noriko

  Department of Urology, Hirosaki University Graduate School of Medicine

• OKAMOTO Teppei

  Department of Urology, Hirosaki University Graduate School of Medicine

• OKAMOTO Akiko

  Department of Urology, Hirosaki University Graduate School of Medicine

• HATAKEYAMA Shingo

  Department of Urology, Hirosaki University Graduate School of Medicine

• YONEYAMA Takahiro

  Department of Urology, Hirosaki University Graduate School of Medicine

• KOIE Takuya

  Department of Urology, Hirosaki University Graduate School of Medicine

• KAMIMURA Noritaka

  Department of Urology, Hirosaki University Graduate School of Medicine

• OHYAMA Chikara

  Department of Urology, Hirosaki University Graduate School of Medicine

Journal

• International journal of clinical oncology

  International journal of clinical oncology 18 (1), 177-182, 2013-02-01

Keywords

• Bladder cancer
• Carboplatin-gemcitabine combination chemotherapy
• AKR1B10
• Recurrence after chemotherapy

Details

• CRID: 1573668925940253568
• NII Article ID: 10031176252
• NII Book ID: AA11086579
• ISSN: 13419625
• Web Site: https://search.jamas.or.jp/link/ui/2014058500
• Text Lang: en
• Data Source:
  • CiNii Articles